By Nigam Arora & Dr. Natasha Arora 517% Gain Congratulations! Arena Pharmaceuticals (ARNA), a biotech associated with marijuana, has received a $100 per share all-cash offer from Pfizer (PFE). ARNA is long from the original Arora buy signal from $16.20. At a $100 cash offer, it represents a gain of 517%. Arena has
There is a big opportunity in marijuana stocks. Millions will be made. There is high risk in individual marijuana stocks. For those who do not want to take high risk, a better way is to use an ETF. If you acted on the Arora signal to buy marijuana ETF
How would you like to wake up to a 50% gain? This is exactly what happened today to the paying subscribers to The Arora Report. GW Pharmaceuticals (GWPH) which is in The Arora Report Marijuana Model Portfolio received a buyout offer from Jazz Pharmaceuticals (JAZZ). The offer is at a
Republicans have finally produced a detailed plan to repeal and replace the Affordable Care Act, also known as Obamacare. Setting aside politics and viewing the plan neutrally, two things jump out. First, the House Republicans’ plan keeps the basic framework of Obamacare. No wonder some are calling it “Obamacare Lite.”
Democrats will fight tooth and nail to save Obamacare, but given the flaws in the plan, they are not likely to succeed. Obamacare in its current form is the walking dead. Trump has said that he will replace Obamacare with something better. In his speeches, Trump outlined certain key points